12 risultati
BACKGROUND OF THE INVENTION
Autoimmune and inflammatory diseases affect more than fifty million Americans. The immune system functions as the body's major defense against diseases caused by invading organisms. This complex system fights disease by killing invaders such as bacteria, viruses,
FIELD OF THE INVENTION
Background of the Invention
Autoimmune and inflammatory diseases affect more than fifty million Americans. The immune system functions as the body's major defense against diseases caused by invading organisms. This complex system fights disease by killing invaders such as
FIELD OF THE INVENTION
The present invention is in the area of pharmaceutical chemistry and specifically relates to novel compounds and pharmaceutical compositions for the treatment of autoimmune and inflammatory disorders. This application claims priority to U.S. patent application Ser. No.
FIELD OF THE INVENTION
The present invention relates to compounds useful as immunosuppressive and anti-inflammatory agents. The compounds have good aqueous solubility and convert to biologically active compounds in vivo.
REFERENCES
Ferrier, R. J. in CARBOHYDRATE CHEMISTRY, Kennedy, J. F., Ed.,
BACKGROUND OF THE INVENTION
Rheumatoid arthritis (RA) is a chronic inflammatory disease of uncertain etiology. Since the cause is unknown, treatment has been directed at suppressing the signs and symptoms of chronic inflammation. Although many agents have been documented to decrease pain and
FIELD OF THE INVENTION
The present invention relates to compounds useful as immunosuppressive, anti-inflammatory and anticancer agents. The compounds have good aqueous solubility and convert to biologically active compounds in vivo.
REFERENCES Boyd, G. V. and Heatherington, K., J. Chem. Soc. Perkin
FIELD OF THE INVENTION
The present invention relates to compounds useful as immunosuppressive, anti-inflammatory and anticancer agents.
REFERENCES
Dai, D. et al., U.S. Pat. No. 6,569,893 (2003).
Fidler, J. M. et al., U.S. Pat. No. 6,620,843 (2003).
Gleichmann, E. et al., Immunol. Today 5:324
FIELD OF THE INVENTION
The present invention relates to prodrugs useful as immunosuppressive, anti-inflammatory and anticancer agents, and methods of their use. The compounds have good aqueous solubility and convert to biologically active compounds in vivo, at a rate which can be modulated by
FIELD OF THE INVENTION
The present invention relates to prodrugs useful as immunosuppressive, anti-inflammatory and anticancer agents, and methods of their use. The compounds have good aqueous solubility and convert to biologically active compounds in vivo, at a rate which can be modulated by
FIELD OF THE INVENTION
The present invention relates to compounds and methods for use in immunosuppressive and anti-inflammatory treatment.
References
Bradley, L., in SELECTED METHODS IN CELLULAR IMMUNOLOGY, W. H. Freeman and Company, San Francisco, pp. 162-164 (1980).
Briggs, J. D., Immunol. Lett.
FIELD OF THE INVENTION
The present invention relates to compounds and methods for use in immunosuppressive and anti-inflammatory treatment, and for reducing male fertility.
REFERENCES
Bradley, L., in SELECTED METHODS IN CELLULAR IMMUNOLOGY, W.H. Freeman and Company, San Francisco, pp. 162-164
BACKGROUND OF THE INVENTION
Rheumatoid arthritis (RA) is a chronic inflammatory disease of uncertain etiology. Since the cause is unknown, treatment has been directed at suppressing the signs and symptoms of chronic inflammation. Although many agents have been documented to decrease pain and